Lupins launches Donepezil Hydrochloride Tablets, 23 mg

In United States

Lupin announced that its US subsidiary, Lupin Pharmaceuticals Inc. has launched its Donepezil Hydrochloride Tablets, 23 mg having received approval from the United States Food & Drug Administration earlier to market a generic equivalent of Eisai Inc's Aricept Tablets, 23 mg. It is indicated for the treatment of dementia of the Alzheimers's type.

Powered by Capital Market - Live News